机译:基于肺部巨噬细胞移植的α-1抗胰蛋白酶缺乏治疗方法
German Ctr Lung Res DZL RG Reprogramming &
Gene Therapy Hannover Germany;
German Ctr Lung Res DZL RG Reprogramming &
Gene Therapy Hannover Germany;
German Ctr Lung Res DZL RG Reprogramming &
Gene Therapy Hannover Germany;
German Ctr Lung Res DZL RG Reprogramming &
Gene Therapy Hannover Germany;
German Ctr Lung Res DZL Dept Resp Med Hannover Germany;
Hannover Med Sch Dept Gastroenterol Hepatol &
Endocrinol RG Stem Cell Biol &
Translat Hepatol;
Hannover Med Sch Clin Gynecol &
Obstet Div Antenatal Diagnost Hannover Germany;
Hannover Med Sch Inst Expt Hematol Hannover Germany;
Hannover Med Sch Inst Expt Hematol Hannover Germany;
German Ctr Lung Res DZL Dept Resp Med Hannover Germany;
German Ctr Lung Res DZL RG Reprogramming &
Gene Therapy Hannover Germany;
机译:基于肺部巨噬细胞移植的α-1抗胰蛋白酶缺乏治疗方法
机译:Alpha-1 Anturigrypsin增强治疗在预测FEV1的严重缺陷患者中提高了存活率10%至60%:NHLBIα-1抗抗核蛋白缺乏登记处的回顾性分析
机译:α-1抗真菌素治疗囊性纤维化和血糖疾病与α-1抗胰蛋白酶缺乏相关的肺病
机译:肺内血管重塑:在COPD和α-1抗胰蛋白酶缺乏的受试者中基于MSCT的评估
机译:Alpha-1抗胰蛋白酶缺乏症研究中的转录组数据分析
机译:Alpha-1 Anturigrypsin增强治疗在预测FEV1的严重缺陷患者中提高了存活率10%至60%:NHLBIα-1抗抗核蛋白缺乏登记处的回顾性分析
机译:>单核细胞和巨噬细胞在α-1抗胰蛋白酶缺乏症 p>